1. Home
  2. ENPH vs TMDX Comparison

ENPH vs TMDX Comparison

Compare ENPH & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enphase Energy Inc.

ENPH

Enphase Energy Inc.

HOLD

Current Price

$33.87

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$122.35

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENPH
TMDX
Founded
2006
1998
Country
United States
United States
Employees
N/A
728
Industry
Semiconductors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.2B
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
ENPH
TMDX
Price
$33.87
$122.35
Analyst Decision
Hold
Buy
Analyst Count
24
8
Target Price
$42.73
$144.25
AVG Volume (30 Days)
5.6M
664.3K
Earning Date
02-03-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
233.44
170.70
EPS
1.44
2.54
Revenue
$1,512,377,000.00
$566,354,000.00
Revenue This Year
$12.30
$38.81
Revenue Next Year
N/A
$20.49
P/E Ratio
$22.23
$47.97
Revenue Growth
20.97
41.20
52 Week Low
$25.78
$55.00
52 Week High
$76.90
$156.00

Technical Indicators

Market Signals
Indicator
ENPH
TMDX
Relative Strength Index (RSI) 59.99 42.70
Support Level $31.70 $121.00
Resistance Level $33.91 $133.29
Average True Range (ATR) 1.26 4.77
MACD 0.08 -0.83
Stochastic Oscillator 75.56 22.79

Price Performance

Historical Comparison
ENPH
TMDX

About ENPH Enphase Energy Inc.

Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: